Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia

Stem Cells Translational Medicine

Volumn 5, Issue 6, 2016, Pages 754-763

  Ophelders, Daan R M G ^a   Wolfs, Tim G A M ^a   Jellema, Reint K ^a,b   Zwanenburg, Alex ^a   Andriessen, Peter ^a,b   Delhaas, Tammo ^a   Ludwig, Anna Kristin ^c   Radtke, Stefan ^c,d   Peters, Vera ^a   Janssen, Leon ^a   Giebel, Bernd ^c   Kramer, Boris W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Brain injury; Exosomes; Extracellular vesicles; Hypoxia ischemia; Mesenchymal stromal cells; Preterm

Indexed keywords

CASPASE 3;

ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN PROTECTION; CD3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; EXOSOME; FETUS; FLOW CYTOMETRY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESENCHYMAL STROMA CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; ANIMAL; BIOLOGICAL THERAPY; BRAIN; BRAIN INJURIES; CELL PROLIFERATION; CYTOLOGY; DISEASE MODEL; HUMAN; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; SHEEP;

ANIMALS; BRAIN; BRAIN INJURIES; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; EXTRACELLULAR VESICLES; FETUS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; MESENCHYMAL STROMAL CELLS; SHEEP;

EID: 84969790691     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0197     Document Type: Article

References (56)

1. Fleiss B, Tann CJ, Degos V et al. Inflammation-induced sensitization of the brain in term infants. Dev Med Child Neurol 2015;57(suppl 3): 17-28.
2. Beck S, Wojdyla D, Say L et al. The worldwide incidence of preterm birth: A systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31-38.
3. Jacobs SE, Berg M, Hunt R et al. Coolingfor newborns with hypoxic ischaemic encepha-lopathy. Cochrane Database Syst Rev 2013; 1:CD003311.
4. Azzopardi D, Robertson NJ, Cowan FM et al. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 2000;106:684-694.
5. Briatore E, Ferrari F, Pomero G et al. EEG findings in cooled asphyxiated newborns and correlation with site and severity of brain damage. Brain Dev 2013;35:420-426.
6. Jellema RK, Wolfs TG, Lima Passos V et al. Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS One 2013;8: e73031.
7. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54-63.
8. Zanotti L, Sarukhan A, Dander E et al. Encapsulated mesenchymal stem cells for in vivo immunomodulation. Leukemia 2013; 27:500-503.
9. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury. Stem Cell Res (Amst) 2010; 4:214-222.
10. Timmers L, Lim SK, Arslan F et al. Reduction of myocardial infarct size by human mesen-chymal stem cell conditioned medium. Stem Cell Res (Amst) 2007;1:129-137.
11. Gnecchi M, He H, Liang OD et al. Para-crine action accounts for marked protection of ischemic heart by Akt-modified mesenchy-mal stem cells. Nat Med 2005;11:367-368.
12. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006; 20:661-669.
13. Katsuda T, Kosaka N, Takeshita F et al. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteo-mics 2013;13:1637-1653.
14. Fleiss B, Guillot PV, Titomanlio L et al. Stem cell therapy for neonatal brain injury. Clin Perinatol 2014;41:133-148.
15. Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20:1053-1067.
16. Xin H, Li Y, Cui Y et al. Systemic administration of exosomes released from mesenchy-mal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013;33:1711-1715.
17. Gatti S, Bruno S, Deregibus MC et al. Microvesicles derived from human adult mesen-chymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011;26:1474-1483.
18. Bruno S, Grange C, Collino F et al. Micro-vesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 2012;7:e33115.
19. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: A novel stem cell-based therapy for cardiovascular disease. Regen Med 2011; 6:481-492.
20. Zhang Y, Chopp M, Meng Y et al. Effect of exosomes derived from multipluripotent mes-enchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 2015;122: 856-867.
21. Doeppner TR, Herz J, Gorgens A et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Translational Medicine 2015;4:1131-1143.
22. Kordelas L, Rebmann V, Ludwig AK et al. MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014;28:970-973.
23. Jellema RK, Lima Passos V, Zwanenburg A et al. Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep. J Neuroin-flammation 2013;10:13.
24. Zwanenburg A, Jellema RK, Jennekens W et al. Heart rate-mediated blood pressure control in preterm f et al sheep under normal and hypoxic-ischemic conditions. Pediatr Res 2013;73:420-426.
25. Andriessen P, Koolen AM, Berendsen RC et al. Cardiovascular fluctuations and transfer function analysis in stable preterm infants. Pediatr Res 2003;53:89-97.
26. Sokolova V, Ludwig AK, Hornung S et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces 2011;87:146-150.
27. Kuypers E, Jellema RK, Ophelders DR et al. Effects of intra-amniotic lipopolysaccha-ride and maternal betamethasone on brain inflammation in f et al sheep. PLoS One 2013;8: e81644.
28. Jellema RK, Lima Passos V, Ophelders DR et al. Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia-ischemia. Exp Neu-rol 2013;250:293-303.
29. Gelman A, Carlin JB, Stern HS et al. Bayesian Data Analysis. Boca Raton, FL: CRC Press, 2014.
30. Ajmo CT Jr., Vernon DO, Collier L et al. The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 2008; 86:2227-2234.
31. Gluckman PD, Wyatt JS, Azzopardi D et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365:663-670.
32. Glass HC, Glidden D, Jeremy RJ et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 2009; 155:318-323.
33. Miller SP, Weiss J, Barnwell A et al. Seizure-associated brain injury in term new-borns with perinatal asphyxia. Neurology 2002;58:542-548.
34. de Vries LS, Toet MC. Amplitude integrated electroencephalography in the full-term newborn. Clin Perinatol 2006;33:619-632.
35. Perlman JM. Therelationshipbetween systemic hemodynamic perturbations and periventricular-intraventricular hemorrhage-A historical perspective. Semin Pediatr Neurolo 2009;16:191-199.
36. Fyfe KL, Yiallourou SR, Wong FY et al. The development of cardiovascular and cerebral vascular control in preterm infants. Sleep Med Rev 2014;18:299-310.
37. Volpe JJ. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8:110-124.
38. Dazzi F, Lopes L, Weng L. Mesenchymal stromal cells: A key player in 'innate tolerance'? Immunology 2012;137:206-213.
39. Waterman RS, Tomchuck SL, Henkle SL et al. A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 pheno-type. PLoS One 2010;5:e10088.
40. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 2013;13:392-402.
41. Li W, Ren G, Huang Y et al. Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ 2012;19: 1505-1513.
42. Hemeda H, Jakob M, Ludwig AK et al. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev 2010;19:693-706.
43. Ranganath SH, Levy O, Inamdar MS et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012;10:244-258.
44. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther 2009;17:939-946.
45. Gregory CA, Ylostalo J, Prockop DJ. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental" niches" in culture: A two-stage hypothesis for regulation of MSC fate. Sci STKE 2005;2005:p e37.
46. Salomon C, Ryan J, Sobrevia L et al. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 2013;8:e68451.
47. Bian S, Zhang L, Duan L et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 2014;92:387-397.
48. Zhang B, Wu X, Zhang X et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4//3-catenin pathway. Stem Cells Translational Medicine 2015;4:513-522.
49. Chen J, Liu Z, Hong MM et al. Proangio-genic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells. PLoS One 2014;9:e115316.
50. Doppner TR, Herz J, Gorgens A et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent post-ischemic immunosuppression. Stem Cells Translational Medicine 2015;4:1131-1143.
51. Dlouhy BJ, Awe O, Rao RC et al. Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report. J Neurosurg Spine 2014;21:618-622.
52. Lener T, Gimona M, Aigner L et al. Applying extracellular vesicles based therapeutics in clinical trials-an ISEV position paper. J Extracell Vesicles 2015;4:30087.
53. Back SA, Riddle A, Dean J et al. The instrumented f et al sheep as a model of cerebral white matter injury in the premature infant. Neuro-therapeutics 2012;9:359-370.
54. Gunn AJ, Bennet L.F et al hypoxia insults and patterns of brain injury: Insights from animal models. Clin Perinatol 2009;36:579-593.
55. Xin H, Li Y, Buller B et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 2012;30:1556-1564.
56. Li T, Yan Y, Wang B et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013;22:845-854.